INDUCTION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) EXPRESSION IN NORMAL HUMAN EOSINOPHILS BY INFLAMMATORY CYTOKINES

被引:72
作者
CZECH, W
KRUTMANN, J
BUDNIK, A
SCHOPF, E
KAPP, A
机构
[1] Department of Dermatology, University of Freiburg, Freiburg
关键词
D O I
10.1111/1523-1747.ep12472082
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Intercellular adhesion molecule-1 (ICAM-1) functions as a ligand for lymphocyte function-associated antigen-1 (LFA-1), and thereby plays a crucial role in mediating cell-cell interactions in inflammatory reactions. Human eosinophils represent important effector cells in allergic skin diseases. To gain more insight into the capacity of eosinophils to physically interact with LFA-1-positive inflammatory leukocytes, in the present study ICAM-1 expression in eosinophils was investigated. Using fluorescence-activated cell sorter analysis, it could be shown that highly purified (greater-than-or-equal-to 95%) eosinophils from peripheral blood of non-atopic individuals do not constitutively express ICAM-1 molecules. However, stimulation of eosinophils with interferon gamma (IFNgamma), tumor-necrosis factor alpha (TNFalpha), or interleukin 3 (IL-3) markedly upregulated ICAM-1 surface expression in a time-and dose-dependent manner. Cytokine-induced ICAM-1 expression in human eosinophils was corroborated by Northern blot analysis. Accordingly, unstimulating eosinophils did not express significant amounts of ICAM-1 mRNA, but ICAM-1 mRNA expression could be markedly induced in these cells upon stimulation with IFNgamma plus TNFalpha. The combination of TNFalpha with either IFNgamma, IL-3, IL-5, or granulocyte/macrophage colony-stimulating factor (GM-CSF) increased ICAM-1 expression in a synergistic fashion, whereas IL-5 or GM-CSF by itself did not induce ICAM-1 expression. Cytokine-induced ICAM-1 expression was specific, because IL1-alpha, IL-1beta, IL-2, IL-4, IL-6, IL-7, IL-8, C5a, and platelet-activating factor did not significantly affect eosinophil ICAM-1 surface expression. In summary, these studies indicate that eosinophils may be activated to express the adhesion molecule ICAM-1 upon stimulation with selected inflammatory cytokines, which may allow adhesion-mediated crosstalk between eosinophils and LFA-1-positive cells. In addition, these data demonstrate for the first time a role for IL-3, IL-5, and GM-CSF in regulation of ICAM-1 expression in human cells.
引用
收藏
页码:417 / 423
页数:7
相关论文
共 41 条
[1]   CHARACTERIZATION OF RECEPTORS FOR HUMAN-TUMOR NECROSIS FACTOR AND THEIR REGULATION BY GAMMA-INTERFERON [J].
AGGARWAL, BB ;
EESSALU, TE ;
HASS, PE .
NATURE, 1985, 318 (6047) :665-667
[2]   CONTRIBUTION OF EOSINOPHIL-DERIVED MEDIATORS IN ASTHMA [J].
BRUIJNZEEL, PLB .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1989, 90 :57-63
[3]   ACTIVE PARTICIPATION OF EOSINOPHILS IN PATCH TEST REACTIONS TO INHALANT ALLERGENS IN PATIENTS WITH ATOPIC-DERMATITIS [J].
BRUYNZEELKOOMEN, CAFM ;
VANWICHEN, DF ;
SPRY, CJF ;
VENGE, P ;
BRUYNZEEL, PLB .
BRITISH JOURNAL OF DERMATOLOGY, 1988, 118 (02) :229-238
[4]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[5]   SERUM EOSINOPHIL CATIONIC PROTEIN (ECP) IS A SENSITIVE MEASURE FOR DISEASE-ACTIVITY IN ATOPIC-DERMATITIS [J].
CZECH, W ;
KRUTMANN, J ;
SCHOPF, E ;
KAPP, A .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (04) :351-355
[6]   THE FUNCTION OF HUMAN INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN THE GENERATION OF AN IMMUNE-RESPONSE [J].
DOUGHERTY, GJ ;
MURDOCH, S ;
HOGG, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (01) :35-39
[7]   ADHESION OF T-LYMPHOBLASTS TO EPIDERMAL-KERATINOCYTES IS REGULATED BY INTERFERON-GAMMA AND IS MEDIATED BY INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) [J].
DUSTIN, ML ;
SINGER, KH ;
TUCK, DT ;
SPRINGER, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) :1323-1340
[8]   EOSINOPHILS AND LYMPHOCYTES-T IN LATE-PHASE ALLERGIC REACTIONS [J].
FREW, AJ ;
KAY, AB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (03) :533-539
[9]  
FUJISAWA T, 1990, J IMMUNOL, V144, P642
[10]  
FUKUDA T, 1985, AM REV RESPIR DIS, V132, P981